ArticleBrain : a journal of neurology2018

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.

Veronick Benoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.